What amount sold does Nanovis, LLC report in Form D filings?

The latest linked filings report $11.3M sold across 10 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Nanovis, LLC's most recent SEC filing?

Nanovis, LLC's most recent Form D filing was on 2020-03-27.

How many investors does Nanovis, LLC have?

The most recent Form D filing lists 5 investor(s).

What type of securities does Nanovis, LLC offer?

Nanovis, LLC's SEC Form D filings indicate equity offerings.

Nanovis, LLC

CIK: 0001464933·Biotechnology·COLUMBIA CITY, IN·Limited Liability Company

Reported Sold

$11,300,133

Total Filings

Identified Offerings

Last Filed

Mar 27, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 27, 2020Form D — New notice

Reported sold: $5,413,520 · Target: Indefinite

Rule 506(b)·5 investors·Section 4(a)(5)

Sep 14, 2017Form D — New notice

Reported sold: $769,548 · Target: $5,500,000

Rule 506(b)·5 investors·Section 4(a)(5)

Sep 16, 2016Form D — New notice

Reported sold: $1,100,000 · Target: $2,845,924

Rule 506(b)·3 investors·Section 4(a)(5)

Sep 16, 2016Form D — New notice

Reported sold: $0 · Target: $3,750,000

Rule 506(b)·0 investors·Section 4(a)(5)

Dec 14, 2015Form D — New notice

Reported sold: $750,000 · Target: $2,501,425

Rule 506(b)·1 investor

Jan 9, 2015Form D — New notice

Reported sold: $2,500,000 · Target: $3,800,000

Rule 506(b)·1 investor·Section 4(a)(5)

Aug 5, 2014Form D — New notice

Reported sold: $372,065 · Target: $600,000

Rule 506(b)·5 investors·Section 4(a)(5)

Mar 7, 2013Form D — New notice

Reported sold: $70,000 · Target: $2,012,640

Rule 506·1 investor·Section 4(6)

Dec 6, 2011Form D/A — Amendment

Reported sold: $225,000 · Target: $1,500,000

Rule 506·3 investors·Section 4(6)

Changed: Reported amount sold, Offering target, Reported investors

Jul 13, 2011Form D — New notice

Reported sold: $0 · Target: $873,680

Rule 506·0 investors·Section 4(6)

Jun 3, 2009Form D — New notice

Reported sold: $100,000 · Target: $950,000

Rule 506·1 investor·Section 4(6)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$5,000,001 - $25,000,000

Reported commissions across identified offerings

$660,000

Amendment Rate

Latest reported sold across 10 identified offerings

$11,300,133

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Matthew Hedrick

Related Person

Appears on 9 filings

Brian More

Related Person

Appears on 9 filings

Brian Emerick

Related Person

Appears on 8 filings

Steve Gerrish

Related Person

Appears on 7 filings

V. Edward Grogg

Related Person

Appears on 5 filings

Brian Emerick

Related Person

Appears on 1 filing

CHRISTOPHER LAMOTHE

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 27, 2020	New	Indefinite	$5,413,520	5
Sep 14, 2017	New	$5,500,000	$769,548	5
Sep 16, 2016	New	$2,845,924	$1,100,000	3
Sep 16, 2016	New	$3,750,000	$0	0
Dec 14, 2015	New	$2,501,425	$750,000	1
Jan 9, 2015	New	$3,800,000	$2,500,000	1
Aug 5, 2014	New	$600,000	$372,065	5
Mar 7, 2013	New	$2,012,640	$70,000	1
Dec 6, 2011	Amendment	$1,500,000	$225,000	3
Jul 13, 2011	New	$873,680	$0	0
Jun 3, 2009	New	$950,000	$100,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

PAHTIA TECHNOLOGIES INC

Biotechnology

Offering target: $500,000

Filed Sep 17, 2026